Photodynamic Therapy: A Brief History

Abstract

Photodynamic therapy (PDT) involves the selective sensitization of tissues to light. A major advance in the field occurred when Thomas Dougherty at the Roswell Park Cancer Institute initiated a series of clinical studies that eventually led to FDA approval of the procedure. This report contains a summary of Dougherty’s contributions and an assessment of where this has led, along with a summary of implications for future drug development.

Keywords

• dougherty
• photodynamic therapy
• hematoporphyrin derivative
• photofrin